Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Return on Equity (2020 - 2025)

Benitec Biopharma (BNTC) has disclosed Return on Equity for 6 consecutive years, with 0.14% as the latest value for Q1 2025.

  • Quarterly Return on Equity rose 174.0% to 0.14% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.14% through Mar 2025, up 174.0% year-over-year, with the annual reading at 0.91% for FY2024, 1149.0% up from the prior year.
  • Return on Equity hit 0.14% in Q1 2025 for Benitec Biopharma, down from 0.16% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.28% in Q3 2024 to a low of 7.78% in Q2 2023.
  • Historically, Return on Equity has averaged 1.66% across 5 years, with a median of 1.32% in 2021.
  • Biggest five-year swings in Return on Equity: crashed -434bps in 2023 and later surged 704bps in 2024.
  • Year by year, Return on Equity stood at 1.32% in 2021, then fell by -19bps to 1.56% in 2022, then increased by 26bps to 1.15% in 2023, then surged by 114bps to 0.16% in 2024, then fell by -10bps to 0.14% in 2025.
  • Business Quant data shows Return on Equity for BNTC at 0.14% in Q1 2025, 0.16% in Q4 2024, and 0.28% in Q3 2024.